North America Wound Debridement products Market Analysis | Coherent Market Insights

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. NORTH AMERICA WOUND DEBRIDEMENT PRODUCTS MARKET ANALYSIS North America Wound Debridement Products Market,ByProduct Type (Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices, Larval Therapy), By Application (Chronic Ulcers, Surgical Wounds, Traumatic Wounds, Burn Cases), End User (Hospital, Ambulatory Surgical Centers, Specialized Clinics, Nursing Facilities, Others), and By Country (U.S., Canada) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

3. North America wound debridement products market is estimated to account for US$ 223.4 Mn in terms of value in 2019 and is expected to reach US$ 378.3 Mn by the end of 2027. Drivers • Increasing cases of injuries/ trauma are expected to propel growth of North America wound debridement products market. For instance, according to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S.

4. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035. • U.S. held dominant position in North America wound debridement products market in 2018, accounting for 88.1% share in terms of value, followed by Canada.

5. Figure.ValueChain Analysis

6. Market Restraints • Surgical debridement and mechanical debridement have a higher risk for bleeding and peri-procedural pain, which limits their adoption, thereby hindering growth of the market.   • Moreover,lackof standard usage guidelines and trained manpower is also expected to limit growth of the market.  Usage of devices such as hydrosurgical debridement devices, low frequency ultrasound, and surgical wound debridement lack standard guidelines and usage indications for various disorders. There is also lack of trained professionals to guide patients in the usage of these devices for different conditions in the long-term treatment plan.

7. Market Opportunities • Market players need to develop and introduce affordable sophisticated systems with easy-to-operate features to boost adoption of wound debridement products in homecare setting. • Moreover, improved reimbursement rates for wound debridement products is also expected aid in growth of the market. Wound debridement products used at home are covered under Medicare Part – B. • Chronic ulcers segment in North America wound debridement products market was valued at US$ 88.4 Mn in 2018 and is expected to reach US$ 175.1 Mn by 2027 at a CAGR of 8.2% during the forecast period.

8. Market Trends • American Society of Plastic Surgeons (ASPS) emphasizes on debridement in case of severe infections. Physicians in the U.S. recommend the use of appropriate and safe forms of debridement where the autolytic is safe. The demand of small debridement equipment such as scalpel and enzymatic solutions is also high in the market. • Increasing prevalence of diabetes in the U.S is leading to high demand for wound debridement products. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million.

9. Competitive Section Major players operating in North America wound debridement products market include, Smith & Nephew plc, Zimmer Biomet, DeRoyal Industries, Inc., Lohmann & Rauscher International, Arobella Medical, LLC, Bactiguard AB, MediWound Ltd., Misonix, Inc., Söring GmbH, BSN Medical, and Derma Sciences Inc.

10. Key Developments • Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2020, Bactiguard AB acquired Vigilenz Medical Devices and Vigilenz Medical Supplies. • Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in December 2019, MediWound Ltd. initiated Phase 2 clinical study of EscharEx, a topical biologic drug candidate designed to enzymatically debride chronic wounds, for the treatment of venous leg ulcers.

11. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/north-america-wound-debridement-products-market-3665

12. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

13. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

14. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/